Status:

NOT_YET_RECRUITING

Lifestyle-modifying Interventions in Low-risk MDS Patients

Lead Sponsor:

Technische Universität Dresden

Conditions:

Myelodysplastic Syndromes

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Myelodysplastic syndromes (MDS) are acquired clonal stem cell diseases characterized by hematopoietic cell dysplasia, cytopenia, and the risk of progression to acute myeloid leukemia. In addition to c...

Eligibility Criteria

Inclusion

  • 18-75 years of age
  • Cytomorphologically confirmed MDS or MDS/MPN according to WHO criteria (incl. MDS-RARS-T, CMML)
  • IPSS-R very low, low, or intermediate
  • Hemoglobin \<11 g/dL (6.8 mmol/l)
  • Non-transfusion dependent (NTD) per IWG 2018 criteria (≤2 blood transfusions within 16 weeks prior to inclusion in the study)
  • ECOG≤2
  • Body mass index (BMI) ≥ 20 kg/m2
  • Written informed consent of the subject after clarification

Exclusion

  • AML
  • MDS IPSS-R high or very high
  • History of HSCT
  • MDS-specific drug therapy (including erythropoietin, erythropoiesis-modulating agents, lenalidomide, iron chelation, hypomethylating agents) ongoing or planned in the next 6 months
  • Diabetes mellitus requiring therapy or any other known metabolic disease
  • Application of systemic cortisone-containing drugs
  • Known psychiatric eating disorder (e.g. anorexia nervosa, bulimia)
  • Physical inability to follow the physical and/or nutritive interventions
  • simultaneous participation in another interventional clinical trial (including within the last 4 weeks before inclusion)
  • addictions or other illnesses that do not allow the person concerned to assess the nature and extent of the clinical trial and its possible consequences
  • pregnant or breastfeeding women
  • indications that the subject is unlikely to adhere to the protocol (e.g., lack of compliance)

Key Trial Info

Start Date :

April 1 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

October 1 2026

Estimated Enrollment :

36 Patients enrolled

Trial Details

Trial ID

NCT05433805

Start Date

April 1 2023

End Date

October 1 2026

Last Update

June 27 2022

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.